piribedil has been researched along with Muscle Rigidity in 2 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Muscle Rigidity: Continuous involuntary sustained muscle contraction which is often a manifestation of BASAL GANGLIA DISEASES. When an affected muscle is passively stretched, the degree of resistance remains constant regardless of the rate at which the muscle is stretched. This feature helps to distinguish rigidity from MUSCLE SPASTICITY. (From Adams et al., Principles of Neurology, 6th ed, p73)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marusiak, J | 1 |
| Jaskólska, A | 1 |
| Koszewicz, M | 1 |
| Budrewicz, S | 1 |
| Jaskólski, A | 1 |
| Engel, J | 1 |
| Granerus, AK | 1 |
| Svanborg, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Myofascial Trigger Points Therapy in Migraine.[NCT05646160] | 100 participants (Anticipated) | Interventional | 2018-01-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for piribedil and Muscle Rigidity
| Article | Year |
|---|---|
Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Body Mass Index; Electromyography; Female; Humans; In | 2012 |
Piribedil in Parkinson's syndrome: a clinical study.
Topics: Activities of Daily Living; Aged; Alkaline Phosphatase; Brain Diseases; Dose-Response Relationship, | 1975 |